Home NDC 42658-024 Fludarabine Phosphate
Product NDC 42658-024
11-digit product format 426580024
Labeler code 42658
Product ID 42658-024_5b82547e-11ca-a21a-e063-6294a90a025b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Fludarabine Phosphate
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Hisun Pharmaceuticals USA, Inc.
Application ANDA220196
Marketing category ANDA
Marketing start 2026-09-01
Substance FLUDARABINE PHOSPHATE
Active strength 25 mg/mL
Pharmacologic classes Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A220196-001 FLUDARABINE PHOSPHATE FLUDARABINE PHOSPHATE 50MG/2ML (25MG/ML) INJECTABLE / INJECTION RS 2026-07-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A220196-001 FLUDARABINE PHOSPHATE 50MG/2ML (25MG/ML) INJECTABLE / INJECTION RS 2026-07-23 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A220196-001 FLUDARABINE PHOSPHATE 50MG/2ML (25MG/ML) INJECTABLE / INJECTION RS 2026-07-23 c2088c7a36db…2026-09-14 22:38:34 2026-08 A220196-001 FLUDARABINE PHOSPHATE 50MG/2ML (25MG/ML) INJECTABLE / INJECTION RS 2026-07-23 84e616aacf4f…2026-08-18 06:07:40 2026-07 A220196-001 FLUDARABINE PHOSPHATE 50MG/2ML (25MG/ML) INJECTABLE / INJECTION RS 2026-07-23 caaa826d4ba7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Fludarabine Phosphate
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength FLUDARABINE PHOSPHATE 25 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1X9VK9O1SC Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1740865 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 42658-024-01 42658002401 1 VIAL, SINGLE-DOSE in 1 CARTON (42658-024-01) / 2 mL in 1 VIAL, SINGLE-DOSE 2026-09-01 No No Current